-+ 0.00%
-+ 0.00%
-+ 0.00%

Regeneron Co-Chief Scientific Officer Andrew Murphy Reports $16.31 Million Disposal of Common Shares

PUBT·11/18/2026 21:08:25
Listen to the news
Regeneron Co-Chief Scientific Officer Andrew Murphy Reports $16.31 Million Disposal of Common Shares
  • Regeneron Pharmaceuticals Co-Chief Scientific Officer Andrew J. Murphy sold 5,011 common shares on November 17, 2026.
  • Reported sale prices ranged from $949.69 to $964.36 per share.
  • Murphy exercised non-qualified stock options for 17,000 common shares at $381.92 per share on November 16, 2026.
  • Another 11,989 common shares were disposed of at $960.02 per share on November 16.
  • Following the transactions, Murphy directly owned 46,779 common shares, with another 4,414 held indirectly through a 401(k) plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regeneron Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001796226-26-000006), on November 18, 2026, and is solely responsible for the information contained therein.